Leia M. Smith

2.4k total citations
31 papers, 1.9k citations indexed

About

Leia M. Smith is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Leia M. Smith has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Leia M. Smith's work include Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Leia M. Smith is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Leia M. Smith collaborates with scholars based in United States, Germany and Czechia. Leia M. Smith's co-authors include Daniel L. Shawler, Richard M. Bartholomew, Robert O. Dillman, Maureen C. Ryan, Albina Nesterova, Michael J. Birrer, Paul Carter, Martha E. Anderson, Powel H. Brown and Steven Duniho and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Leia M. Smith

31 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leia M. Smith United States	21	893	830	535	416	201	31	1.9k
Li-Zhi Mi United States	20	1.5k 1.7×	597 0.7×	379 0.7×	450 1.1×	162 0.8×	30	2.6k
Jessica R. Kirshner United States	18	842 0.9×	1.6k 1.9×	330 0.6×	403 1.0×	204 1.0×	37	2.6k
Christian‐Jacques Larsen France	30	1.6k 1.8×	819 1.0×	180 0.3×	496 1.2×	268 1.3×	107	2.6k
RA Ashmun United States	19	1.1k 1.3×	976 1.2×	242 0.5×	487 1.2×	268 1.3×	31	2.3k
Viia Valge-Archer United Kingdom	19	1.1k 1.2×	1.0k 1.2×	238 0.4×	1.2k 2.8×	373 1.9×	27	2.4k
Vanessa Chisholm United States	12	1.6k 1.8×	607 0.7×	422 0.8×	175 0.4×	454 2.3×	14	2.4k
Gundram Jung Germany	31	871 1.0×	1.4k 1.7×	729 1.4×	1.7k 4.0×	193 1.0×	114	2.9k
Andréas Tsapis France	29	885 1.0×	607 0.7×	303 0.6×	1.3k 3.1×	370 1.8×	71	2.8k
An Song United States	20	1.1k 1.2×	381 0.5×	684 1.3×	610 1.5×	110 0.5×	39	1.8k
Daniel Harari Israel	17	1.0k 1.1×	672 0.8×	335 0.6×	395 0.9×	97 0.5×	33	2.0k

Countries citing papers authored by Leia M. Smith

Since Specialization

Citations

This map shows the geographic impact of Leia M. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leia M. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leia M. Smith more than expected).

Fields of papers citing papers by Leia M. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leia M. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leia M. Smith. The network helps show where Leia M. Smith may publish in the future.

Co-authorship network of co-authors of Leia M. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Leia M. Smith. A scholar is included among the top collaborators of Leia M. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leia M. Smith. Leia M. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ye, Guo-jie, Ewa Budzynski, T. Michael Nork, et al.. (2016). Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia. 1 indexed citations

2.

Ye, Guo-jie, Ewa Budzynski, T. Michael Nork, et al.. (2016). Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia. PubMed. 27(1). 27–36. 20 indexed citations

3.

Ye, Guo-jie, Ewa Budzynski, T. Michael Nork, et al.. (2016). Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia. PubMed. 27(1). 37–48. 53 indexed citations

4.

Sussman, Django, Leia M. Smith, Martha E. Anderson, et al.. (2014). SGN–LIV1A: A Novel Antibody–Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer. Molecular Cancer Therapeutics. 13(12). 2991–3000. 104 indexed citations

5.

Farley, John, Leia M. Smith, Kathleen M. Darcy, et al.. (2011). Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: A gynecologic oncology group study. Gynecologic Oncology. 121(2). 395–401. 7 indexed citations

6.

Ryan, Maureen C., Heather Kostner, Karen A. Gordon, et al.. (2010). Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75. British Journal of Cancer. 103(5). 676–684. 68 indexed citations

7.

McEarchern, Julie A., Leia M. Smith, Charlotte F. McDonagh, et al.. (2008). Preclinical Characterization of SGN-70, a Humanized Antibody Directed against CD70. Clinical Cancer Research. 14(23). 7763–7772. 70 indexed citations

8.

Smith, Leia M., Albina Nesterova, Maureen C. Ryan, et al.. (2008). CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. British Journal of Cancer. 99(1). 100–109. 218 indexed citations

9.

Kraemer, Susan M., Sue Kyes, Gautam Aggarwal, et al.. (2007). Patterns of gene recombination shape var gene repertoires in Plasmodium falciparum: comparisons of geographically diverse isolates. BMC Genomics. 8(1). 45–45. 145 indexed citations

10.

Smith, Leia M., Albina Nesterova, Stephen C. Alley, Michael Torgov, & Paul J. Carter. (2006). Potent cytotoxicity of an auristatin-containing antibody-drug conjugate targeting melanoma cells expressing melanotransferrin/p97. Molecular Cancer Therapeutics. 5(6). 1474–1482. 76 indexed citations

11.

Law, Che‐Leung, Julie A. McEarchern, Charles G. Cerveny, et al.. (2005). The Humanized Anti-CD40 Monoclonal Antibody SGN-40 Targets Hodgkin’s Disease Cells through Multiple Mechanisms.. Blood. 106(11). 1476–1476. 5 indexed citations

12.

Zhang, Xintian, et al.. (2005). Caveolin-1 down-regulation activates estrogen receptor alpha expression and leads to 17beta-estradiol-stimulated mammary tumorigenesis.. PubMed. 25(1A). 369–75. 25 indexed citations

13.

Springer, Amy, et al.. (2004). Functional interdependence of the DBLβ domain and c2 region for binding of the Plasmodium falciparum variant antigen to ICAM-1. Molecular and Biochemical Parasitology. 137(1). 55–64. 33 indexed citations

14.

Feng, Lixin, et al.. (2004). Improved potency of cisplatin by hydrophobic ion pairing. Cancer Chemotherapy and Pharmacology. 54(5). 441–448. 31 indexed citations

15.

Carter, Paul, Leia M. Smith, & Maureen C. Ryan. (2004). Identification and validation of cell surface antigens for antibody targeting in oncology. Endocrine Related Cancer. 11(4). 659–687. 90 indexed citations

16.

Zhou, Jun, D. Craig Allred, Ingalill Avis, et al.. (2001). Differential Expression of the Early Lung Cancer Detection Marker, Heterogeneous Nuclear Ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in Normal Breast and Neoplastic Breast Cancer. Breast Cancer Research and Treatment. 66(3). 217–224. 92 indexed citations

17.

Krett, Nancy, Evelyn T. Maizels, Richard E. Cutler, et al.. (1999). Regulation of protein kinase C δ by estrogen in the MCF-7 human breast cancer cell line. Molecular and Cellular Endocrinology. 148(1-2). 109–118. 44 indexed citations

18.

Smith, Leia M., Scott Wise, Denver T. Hendricks, et al.. (1999). cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene. 18(44). 6063–6070. 183 indexed citations

19.

Vorobiof, Daniel, L. Goedhals, A. Gudgeon, et al.. (1997). Phase II study of i.v navelbine (NVB) and doxorubicln (DOX) in previously untreated advanced breast cancer (ABC). European Journal of Cancer. 33. S155–S155. 3 indexed citations

20.

Rowinsky, Eric K., Leia M. Smith, Gladys Rodriguez, et al.. (1997). Docetaxel in combination with fluorouracil: study design and preliminary results.. PubMed. 11(6 Suppl 6). 33–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact